Through strong industry cooperation, significant investment, and smart policy backing, API manufacturing may become self-reliant
Illexcor is developing a first-in-class oral drug that directly targets the root cause of SCD
Announces Rs. 317 crore investment in new recycling plant
Overall investment in the US facility is estimated around US$50 million
This Yearbook aims to distinguish those companies that have demonstrated strengths in corporate sustainability
Dr. Prabhavathi brings over 14 years of unparalleled experience in pediatrics and a specialized focus on neurodevelopmental disorders
Offers affordable, high-quality solutions for diabetes care
During the quarter, the company posted Revenue from operations at Rs. 5,269 crore as compared to Rs. 4,505 crore in Q3 FY25, posting a growth of 17 per cent
The company will showcase groundbreaking innovations from its Pharma and Nutrition divisions, highlighting key ingredients and formulations designed to support holistic well-being
Subscribe To Our Newsletter & Stay Updated
